AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Serum and Salivary Leptin Levels in Children With Adenoid/Adenotonsillar Hypertrophy

Recruitingn/aAges 3 Years - 18 YearsAllHarran University
💬

In plain words

What the trial is, and whether it could suit you

Adenoid and adenotonsillar hypertrophy are among the most common causes of nasal obstruction, snoring and sleep-disordered breathing in children, and chronic upper airway obstruction may affect growth, appetite and energy metabolism. Leptin is an adipose tissue-derived hormone that regulates appetite and energy balance. This prospective case-control study aims to compare serum and salivary leptin levels between children with adenoid/adenotonsillar hypertrophy and age- and sex-matched children without adenoid/adenotonsillar hypertrophy, to evaluate the relationship of leptin levels with height, weight and body mass index, and to assess whether salivary leptin, a non-invasive measure, reflects serum leptin levels.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Adenoid/Adenotonsillar Hypertrophy Group Inclusion Criteria: * Age 3 to 18 years * Diagnosis of adenoid hypertrophy or adenoid and palatine tonsil hypertrophy at the Otorhinolaryngology outpatient clinic by clinical examination with or without endoscopic evaluation * Stable general condition without known chronic systemic disease * No medical contraindication to venous blood and saliva sampling * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: * Signs of acute upper or lower respiratory tract infection at the time of sampling or within the previous 2 weeks * Chronic endocrine, metabolic, cardiac, renal, hepatic or hematologic systemic disease * Obesity, growth retardation or a clinically diagnosed nutritional disorder * Previous adenoidectomy or adenotonsillectomy * Use of systemic corticosteroids, hormone preparations or immunomodulatory drugs within the last 3 months * Insufficient cooperation during clinical evaluation or sampling, or inability to obtain an adequate blood and/or saliva sample * Lack of written informed consent from a parent or legal guardian Control Group Inclusion Criteria: * Age 3 to 18 years * No adenoid or adenotonsillar hypertrophy on clinical and endoscopic evaluation * No history of nasal obstruction, chronic snoring or sleep-disordered breathing * Similar age and sex distribution to the patient group * No known chronic systemic disease and no medical contraindication to venous blood and saliva sampling * Written informed consent obtained from a parent or legal guardian Exclusion Criteria: \* Same exclusion criteria as the patient group
💊

What it tests

  • Blood and saliva sampling
📍

Where

1 site
Harran University Faculty of Medicine Hospital, Department of Otorhinolaryngology
Sanliurfa, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy